Mayfair Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 18-07-2024
- Paid Up Capital ₹ 2.50 Cr
as on 18-07-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 32.50 Cr
as on 18-07-2024
- Revenue 105.03%
(FY 2023)
- Profit 98.72%
(FY 2023)
- Ebitda -2475.81%
(FY 2023)
- Net Worth 64.16%
(FY 2023)
- Total Assets -49.36%
(FY 2023)
About Mayfair Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company has closed loans amounting to ₹32.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anand Ramachandran and Chaman Kapoor serve as directors at the Company.
- CIN/LLPIN
U24232HP2003PTC026304
- Company No.
026304
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Distt Una, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mayfair Biotech Private Limited offer?
Mayfair Biotech Private Limited offers a wide range of products and services, including Adhesives, Glue and Sealants, Acrylic Sealants, Industrial Chemicals & Supplies, Paper Chemical, Construction Chemical, Sika Construction Chemical, Textile Chemical.
Who are the key members and board of directors at Mayfair Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Ramachandran  | Managing Director | 22-Aug-2003 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chaman Kapoor | Director | 07-Apr-2010 | Current |
Financial Performance of Mayfair Biotech.
Mayfair Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 105.03% increase. The company also saw a substantial improvement in profitability, with a 98.72% increase in profit. The company's net worth Soared by an impressive increase of 64.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mayfair Biotech?
In 2023, Mayfair Biotech had a promoter holding of 84.00% and a public holding of 16.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ankit Petroproducts Private LimitedActive 34 years 9 monthsAnand Ramachandran and Chaman Kapoor are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 27 Jul 2012 | ₹14.20 Cr | Satisfied |
Development Credit Bank Limited Creation Date: 24 Jul 2010 | ₹9.00 Cr | Satisfied |
Development Credit Bank Limited Creation Date: 24 Jul 2010 | ₹9.00 Cr | Satisfied |
How Many Employees Work at Mayfair Biotech?
Unlock and access historical data on people associated with Mayfair Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mayfair Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mayfair Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
